Eptifibatide and haematocrit decreased Patient Reports February 12, 2012

Eptifibatide Side Effects Report #5108339-1
Eptifibatide side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2006. Male patient, 66 years of age, was diagnosed with percutaneous coronary intervention, postoperative care and was treated with Eptifibatide. After drug was administered, patient experienced the following side effects: abdominal pain lower, catheter related complication, coagulation time prolonged, haematocrit decreased, haematoma, haemorrhage, post procedural complication. Eptifibatide dosage: unknown. During the same period patient was treated with PLAVIX. Patient was hospitalized. Patient recovered.

Eptifibatide Side Effects Report #4809907-4
Eptifibatide side effect was reported by a Pharmacist from UNITED STATES on Oct 24, 2005. Male patient, 70 years of age, was treated with Eptifibatide. After drug was administered, patient experienced the following side effects: duodenitis, gastritis erosive, haematochezia, haematocrit decreased, post procedural complication. Eptifibatide dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient recovered.

Eptifibatide Side Effects Report #4810473-8
Eptifibatide side effect was reported by a Pharmacist from UNITED STATES on Oct 25, 2005. Male patient, 69 years of age, was treated with Eptifibatide. After drug was administered, patient experienced the following side effects: epistaxis, haematocrit decreased, haemoptysis. Eptifibatide dosage: FOLLOWED BY 7.5MG/HR. During the same period patient was treated with ENOXAPARIN, ACETAMINOPHEN, AMITRIPTYLINE, ASPIRIN, CHLORIDAZEPOXIDE, DOCUSATE, HUMULIN R, MAGNESIUM HYDROXIDE. Patient was hospitalized. Patient recovered.

Eptifibatide Side Effects Report #5574374-2
Eptifibatide side effect was reported by a Physician from UNITED STATES on Dec 13, 2007. Female patient, 67 years of age, weighting 119.1 lb, was diagnosed with percutaneous coronary intervention and was treated with Eptifibatide. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, post procedural complication, wound secretion. Eptifibatide dosage: 3.5 ML; QH; IV. During the same period patient was treated with CLOPIDOGREL, HEPARIN. Patient was hospitalized. Patient recovered.


Eptifibatide Side Effects Report #5587744-3
Eptifibatide side effect was reported by a Physician from UNITED STATES on Jan 02, 2008. Female patient, 67 years of age, weighting 119.1 lb, was diagnosed with percutaneous coronary intervention and was treated with Eptifibatide. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, wound secretion. Eptifibatide dosage: unknown. During the same period patient was treated with CLOPIDOGREL, HEPARIN, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.